SGLT2 inhibitors in cardiovascular medicine

被引：23
|
作者：
Varzideh, Fahimeh [1 ,2 ]
Kansakar, Urna [1 ,2 ]
Santulli, Gaetano [1 ,2 ]
机构：
[1] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab FIDAM, Einstein Mt Sinai Diabet Res Ctr ES DRC, Dept Med, 1300 Morris Pk Ave, New York, NY 10461 USA
[2] Albert Einstein Coll Med, Einstein Inst Aging Res, Wilf Family Cardiovasc Res Inst, Dept Mol Pharmacol, 1300 Morris Pk Ave, New York, NY 10461 USA
来源：
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY | 2021年 / 7卷 / 04期
关键词：
D O I：
10.1093/ehjcvp/pvab039
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E67 / E68
页数：2
相关论文
共 50 条
  • [1] Cardiovascular safety of SGLT2 inhibitors
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2016, 5 (02): : 62 - 65
  • [2] Cardiovascular benefit of SGLT2 inhibitors
    Mohebi, Reza
    Januzzi, James L.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (03) : 142 - 155
  • [3] Cardiovascular effects of SGLT2 inhibitors
    Drexel, H.
    Saely, C. H.
    DIABETOLOGE, 2016, 12 (03): : 195 - 200
  • [4] SGLT2 Inhibitors in Cardiovascular Medicine: Panacea or Pandora's Box?
    Ferreira, Stella de Aguiar Trigueirinho
    de Oliveira, Lucas Lentini Herling
    de Assis, Arthur Cicupira Rodrigues
    Soares, Paulo Rogerio
    Scudeler, Thiago Luis
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (11)
  • [5] Are the antidiabetic SGLT2 inhibitors a cardiovascular treatment?
    Vargas Delgado, Ariana P.
    Requena Ibanez, Juan Antonio
    Santos-Gallego, Carlos G.
    Jose Badimon, Juan
    CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2021, 33 (01): : 33 - 40
  • [6] Efficacy and cardiovascular safety of SGLT2 Inhibitors
    Fernandez, Cornelius James
    Nevins, Abisha Graciano
    Nawaz, Shasta
    Nazir, Tahir
    Hanna, Fahmy W. F.
    CURRENT DRUG SAFETY, 2021, 16 (02) : 178 - 196
  • [7] Investigating Cardiovascular Benefits of SGLT2 Inhibitors
    Sieracki, Lauren
    Sordi, Christina
    Ostroff, Marissa L.
    Ostroff, Jared L.
    US PHARMACIST, 2022, 47 (11) : 17 - 22
  • [8] The Role of SGLT2 Inhibitors in Cardiovascular Management
    Wang, Andy
    Mahmood, Uzair
    Dey, Subo
    Fishkin, Tzvi
    Frishman, William H.
    Aronow, Wilbert S.
    CARDIOLOGY IN REVIEW, 2025, 33 (01) : 22 - 26
  • [9] Effects of SGLT2 inhibitors on cardiovascular outcomes
    Foote, Celine
    Perkovic, Vlado
    Neal, Bruce
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 117 - 123
  • [10] A review of cardiovascular benefits of SGLT2 inhibitors
    Zhang, Yingxia
    Han, Qinghua
    MEDICINE, 2022, 101 (36) : E30310
12345